Emergent cleared to restart Covid-19 vaccine manufacturing at Baltimore plant

Emergent cleared to restart Covid-19 vaccine manufacturing at Baltimore plant

bizjournals

Published

The vaccine maker would resume operations for the first time in more than three months.

Full Article